Efficiency of prenatal counselling for sickle cell disease in Guadeloupe

Genetic Counseling

Volumn 8, Issue 1, 1997, Pages 25-32

  Alexandre, L ^a   Keclard, L ^a   Romana, M ^a   Saint Martin, C ^a   Lavocat Bernard, E ^a   Midonet, N ^a   Diara, J P ^a   Petras, M ^a   Berchel, C ^a   Merault, G ^a  

^a Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

Author keywords

Genetic counselling; Induced abortion; Prenatal diagnosis; Sickle cell disease

Indexed keywords

ARTICLE; GENETIC COUNSELING; GESTATIONAL AGE; GUADELOUPE; HIGH RISK POPULATION; HUMAN; INDUCED ABORTION; MULTIPARA; NORMAL HUMAN; PRENATAL DIAGNOSIS; SICKLE CELL ANEMIA;

ABORTION, INDUCED; ANEMIA, SICKLE CELL; FEMALE; GENETIC COUNSELING; GUADELOUPE; HEMOGLOBINS; HUMANS; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 8244257350     PISSN: 10158146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. ALTER B.P.: Anteaatal diagnosis. Summery of results. Ann. N. Y. Acad. Sci., 1990, 612, 237-250.
2. ANIONWU E.N., PATEL N., KANJI G., RENGES H. and BROZOVIC M.: Counseling for prenatal diagnosis of sickle cell disease and β-thalassemia major: a four year experience. J. Med. Genet., 1988, 25, 769-772.
3. BASSET P., BEUZARD Y., GAREL M.C. and ROSA J.: Isoelectric focusing of hemoglobins and hemoglobinapathies: its application to screening, to characterization of 70 variants, and to study of modified fractions of normal hemoglobins. Blood, 1978, 51, 971.
4. CAO A., COSSU P., MONNI G. and ROSATELLI M.C.: Chorionic villus sampling and acceptance rate of prenatal diagnosis. Prenat. Diagn., 1987, 7, 531-533.
5. CAO A., ROSATELLI M.C., LEONI G.B., TUVERI T., SCALAS M.T., MONNI G., OLLA G. and GALANELLO R.: Antenatal diagnosis of beta-thalassemia in Sardinia. Ann. N. Y. Acad. Sci., 1990, 612, 215-225.
6. CAO A., ROSATELLI M.C. and GALANELLO R.: Population-based genetic screening. Curr. Op. in Genet. and Develop., 1991, 1, 48-53.
7. DRISCOLL MC., LERNER N., ANYANE Y. K., MAIDMAN J., WARBUTON D., SCHAEFER R. K., HSU R., INCE C., MALIN J. and PALLAI M.: Prenatal diagnosis of sickle hemoglobinopathies the experience of the Columbia University Comprehensive Center for sickle Cell Disease. Am. J. Hum. Genet., 1987, 40, 548-558.
8. GASTON M.H., VERTER J.J., WOODS G., PEGELOW C., KELLEHER J., PRESSBURY G., ZARKOWSKY H., VICHINSKY E., IYER R. and LOBEL J.S.: Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N. Engl. J. Med., 1986, 316, 656-661.
9. HUISSMAN T.H.J.: Separation of hemoglobins and hemoglobin chains by high-performance liquid chromatography. J. Chromatogr., 1987, 418, 277-304.
10. KAZAZIAN H.H.J., PHILIPS D.G., DOWMING C.E. and BOEHN C.D.: Prenatal diagnosis of sickle cell anemia. Ann. N. Y. Acad. Sci., 1989, 565, 44-47.
11. s Haplotypes, α-globin gene status and hematological data of sickle cell disease patients in Guadeloupe (F.W.I.). Hemoglobin, 1996, 20, 63-74.
12. LONGINOTTI M., PISTIDA P., OGGIANO L., GUISO L., PROGHERY L., DORE F., PARDINI S., BONFIGLI S., RIMINI E., ANGIONI S., MULAS P. and INZAINA A.: A 12-year preventive program for β-thalassemia in Northen Sardinia. Clin. Genet. 1994, 46, 238-243.
13. LOUKOPOULOS D., HADJI A., PAPADAKISM., KARABABA P., SINOPOULOU K., BOUSSIOU M., KOLIA P., XENAKIS M., ANTSAKI A. and MESOGHITIS S.: Prenatal diagnosis of thalassemia and of sickle cell syndromes in Greece. Ann. N. Y. Acad. Sci., 1990, 612, 226-236.
14. Me GOVERN D., GOLDBERG J. and DESNICK R.: Acceptability of chorionic villi sampling for prenatal diagnosis. Am. J. Obstet., 1968, 155, 25-29.
15. MERAULT G., DIARA J.P. and DE CAUNES E: Dépistage néonatal et prise en charge coordonnée de la Drépanocytose en Guadeloupe. Drépanocytose et Santé Publique - Colloque CIE INSERM, 1990, 32.
16. PETROU M., BRUGIATELLI M., WARD R. T. H. and MODELL B.: Factors affecting the uptake of prenatal diagnosis for sickle cell disease. J. Med. Genet., 1992, 29820-823.
17. ROBINSON G., GARNER D., OLMSTED M., SHIME M.A., HUTTON E. and CRAWFORD B.: Anxiety reduction after chorionic vlllus sampling and genetic amniocentesis. Am. J. Obstet. Gynecol., 1988, 159, 953-956.
18. ROMANA M., KECLARD L., GUILLEMIN G., LAVOCAT-BERNARD E., SAINT-MARTIN C., BERCHEL C. and MERAULT G.: Molecular characterization of β-thalassemia mutations in Guadeloupe. Am. J. Hemat., in press.
19. ROWLEY P.T.: Prenatal Diagnosis for Sickle Cell Disease. A survey of the United States an Canada. Ann. N.Y. Acad. Sc 1989, 565, 48-52.
20. SAIKI R. K., CHANG C. A., LEVENSON C.H., WARREN T.C., BOEHM C.D., KAZAZIAN H. H. J. and ERLICH H. A.: Diagnosis of sickle cell anemia and β-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. N. Engl. J. Med., 1988, 319, 537-541.
21. SCHNEIDER R.G., HOSTY T.S., TOMLIN G. and ATKINS R.: Identification of hemoglobins and hemoglobinopathies by electrophoresis on cellulose acetate plates impregnate with citrate agar. Clin Chem., 1974, 20, 74.
22. WANG X., SEAMAN C., PAIK M., CHEN T., BANK A. and PIOMELLI S.: Experience with 500 prenatal diagnoses of sickle diseases: the effect of gestational age on affected pregnancy outcome. Prenat. Diagn., 1994, 14, 851-857.
23. WHO Meeting: Community control of hereditary anemias Bulletin of the World Health Organization, 1983, 61, 63-80.
24. WHO combined report of two meetings: The Haemoglobinopathies in Europe, Brussels 14 March 1986 and Paris 20-21 March 1987, WHO/Eur/ICP/MCH 110.
25. WHO Working Group: Feasibility study on Hereditary Disease Community control programs, Cagliari, Sardinia 8-9 April 1989, WHO/HDP/H A/WG/89.1.
26. ZOHOUN I. S., MERAULT G., REINETTE P. and ROSA J.: Politiques de santé et Drèpanocytose, Rev. Prat., 1992, 42, 1873-1877.